Activist Investor Targets Nova Nordisk Amid Leadership Changes

On this episode of Stock Movers:
- Diageo is considering options for its ownership of the Indian Premier League cricket franchise Royal Challengers Bengaluru, according to people familiar with the matter.
- UBS shares drop as much as 7.4%, the most in two months and erasing all of Friday’s gains that followed the Swiss government proposing new rules that could see the bank hold up to $26 billion in fresh capital. Vontobel analysts say it will impact the bank’s competitiveness.
- Activist hedge fund Parvus Asset Management is building a stake in Ozempic-maker Novo Nordisk, the Financial Times reports, citing unidentified people with knowledge of the details.

See omnystudio.com/listener for privacy information.